August 08, 2023
The Drug Enforcement Administration (DEA) is planning two listening sessions next month as it considers telehealth’s role for the prescription of certain medications and treatments.
On September 12 and 13, the DEA will hear from patients, providers, and other behavioral health professionals about the role of virtual prescriptions and when in-person medical evaluation is needed. Following public feedback, the DEA has signaled it’s open to a separate special registration for certain controlled substances.
“DEA recognizes the importance of telemedicine in providing Americans with access to needed medications, and DEA has been, and remains, committed to expanding access to telemedicine in a way that puts patients—and their safety—first, is simple to understand and apply, reflects technological advancements, and is consistent with lessons learned during the COVID-19 PHE and the ongoing opioid epidemic,” the agency said last week.
Here’s what you need to know:
People wishing to attend the event online must register online by August 21. The event also will be streamed online.
Additional information is available online.
For questions, contact Jennifer Jordan, vice president, regulatory, behavioral health and equity strategy, or Kate McCale, senior director, compliance support.
Tags: Access to Care | Substance Use Disorder | Telehealth | Regulatory Advocacy | Behavioral Health
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.